@prefix dbo: .
@prefix dbr: .
dbr:Barbara_Lee dbo:wikiPageWikiLink dbr:Breakthrough_infection .
@prefix foaf: .
@prefix wikipedia-en: .
wikipedia-en:Breakthrough_infection foaf:primaryTopic dbr:Breakthrough_infection .
@prefix ns4: .
ns4:AIDS-related_articles dbo:wikiPageWikiLink dbr:Breakthrough_infection .
@prefix rdf: .
dbr:Breakthrough_infection rdf:type dbo:Disease .
@prefix owl: .
dbr:Breakthrough_infection rdf:type owl:Thing .
@prefix rdfs: .
dbr:Breakthrough_infection rdfs:label "Infecci\u00F3n posvacunaci\u00F3n"@es ,
"Breakthrough infection"@en ,
"\u7A81\u7834\u6027\u611F\u67D3"@zh ,
"Impfdurchbruch"@de ,
"\u0639\u062F\u0648\u0649 \u0627\u062E\u062A\u0631\u0627\u0642"@ar ,
"Infezione postvaccinale"@it ,
"\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3"@ja ,
"\uB3CC\uD30C \uAC10\uC5FC"@ko ,
"Genombrottsinfektion"@sv ;
rdfs:comment "A breakthrough infection is a case of illness in which a vaccinated individual becomes infected with the illness, because the vaccine has failed to provide complete immunity against the pathogen (currently only viruses). Breakthrough infections have been identified in individuals immunized against a variety of diseases including mumps, varicella (Chickenpox), influenza, and COVID-19. The characteristics of the breakthrough infection are dependent on the virus itself. Often, infection of the vaccinated individual results in milder symptoms and shorter duration than if the infection were contracted naturally."@en ,
"Un'infezione postvaccinale \u00E8 un caso di malattia in cui un individuo vaccinato si ammala della stessa malattia che il vaccino dovrebbe prevenire. Semplicemente, si verifica quando i vaccini non riescono a fornire l'immunit\u00E0 contro l'agente patogeno a cui sono destinati. Infezioni postvaccinali sono state identificate in individui immunizzati contro una variet\u00E0 di malattie diverse, tra cui la parotite, la varicella e l'influenza. La causa delle infezioni postvaccinali dipende dal virus stesso. Spesso, l'infezione nell'individuo vaccinato provoca sintomi pi\u00F9 lievi ed \u00E8 di durata inferiore rispetto a quando l'infezione \u00E8 stata contratta normalmente."@it ,
"En genombrottsinfektion avser en infektion som sker n\u00E4r en vaccinerad individ blir sjuk av samma virus som vaccinet skulle skydda mot. Infektionen intr\u00E4ffar n\u00E4r vaccinet inte ger immunitet mot det patogen som det ska skydda mot. Genombrottsinfektioner har identifierats hos individer som har f\u00E5tt vaccin mot olika sjukdomar s\u00E5som p\u00E5ssjuka, vattkoppor och influensa. Hur sjuk en individ blir av infektionen beror p\u00E5 virustypen, men oftast f\u00E5r den som \u00E4r vaccinerad mildare symptom och under en kortare period \u00E4n om denne inte var vaccinerad."@sv ,
"Als Impfdurchbruch (auch Durchbruchsinfektion (englisch vaccine breakthrough infection) bzw. sekund\u00E4res Impfversagen) wird eine symptomatische Infektion bei einem Geimpften bezeichnet, die mittels RT-PCR-Test oder Erregerisolierung diagnostiziert wurde. F\u00FCr Impfdurchbr\u00FCche gibt es verschiedene Ursachen. Eine M\u00F6glichkeit ist eine Mutation des Pathogens, gegen das geimpft worden ist. Wenn dadurch der Erreger nicht mehr vom Immunsystem erkannt wird, kommt es trotz einer vorangegangenen Impfung oder einer \u00FCberstandenen Infektion zu einer Erkrankung."@de ,
"Una infecci\u00F3n posvacunaci\u00F3n es un caso de enfermedad en el que un individuo vacunado se enferma de la misma enfermedad que la vacuna debe prevenir. Simplemente, ocurre cuando las vacunas no logran proporcionar inmunidad contra el pat\u00F3geno para el que est\u00E1n dise\u00F1adas. Se han identificado infecciones posvacunaci\u00F3n en personas inmunizadas contra una variedad de enfermedades diferentes, incluyendo paperas, varicela e influenza.\u200B\u200B\u200B El car\u00E1cter de las infecciones posvacunaci\u00F3n depende del virus en s\u00ED. A menudo, la infecci\u00F3n en el individuo vacunado produce s\u00EDntomas m\u00E1s leves y es de menor duraci\u00F3n que si la infecci\u00F3n se contrajera naturalmente.\u200B"@es ,
"\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\uFF08\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u304B\u3093\u305B\u3093\u3001Breakthrough infection\uFF09\u3068\u306F\u3001\u30EF\u30AF\u30C1\u30F3\u3092\u63A5\u7A2E\u3057\u305F\u60A3\u8005\u304C\u3001\u305D\u306E\u30EF\u30AF\u30C1\u30F3\u304C\u4E88\u9632\u3059\u308B\u7B48\u306E\u3082\u306E\u3068\u540C\u3058\u75C5\u539F\u4F53\u306B\u611F\u67D3\u3057\u3066\u3057\u307E\u3046\u4E8B\u3092\u6307\u3059\u3002\u30EF\u30AF\u30C1\u30F3\u3092\u6253\u3063\u3066\u3044\u3066\u3082\u611F\u67D3\u3059\u308B\u7406\u7531\u3068\u3057\u3066\u306F\u3001\u8840\u4E2D\u306B\u6297\u4F53\u304C\u5B58\u5728\u3057\u3066\u3082\u7C98\u819C\u306A\u3069\u3067\u306F\u305D\u306E\u50CD\u304D\u304C\u5F31\u304F\u4E88\u9632\u3057\u304D\u308C\u306A\u3044\u305F\u3081\u3001\u307E\u305F\u3001\u75C5\u539F\u4F53\u306E\u5909\u7570\u306B\u3088\u308A\u6297\u4F53\u304C\u5341\u5206\u306B\u50CD\u304B\u305A\u306B\u611F\u67D3\u3057\u3066\u3057\u307E\u3046\u3053\u3068\u304C\u8003\u3048\u3089\u308C\u308B\u3002\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\u306F\u3001\u304A\u305F\u3075\u304F\u98A8\u90AA\u3001\u6C34\u75B1\u7621\u3001\u30A4\u30F3\u30D5\u30EB\u30A8\u30F3\u30B6\u306A\u3069\u3001\u69D8\u3005\u306A\u75C5\u6C17\u306E\u4E88\u9632\u63A5\u7A2E\u3092\u53D7\u3051\u305F\u60A3\u8005\u306B\u78BA\u8A8D\u3055\u308C\u3066\u3044\u308B\u3002\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\u306E\u7279\u5FB4\u306F\u3001\u30A6\u30A4\u30EB\u30B9\u81EA\u4F53\u306B\u4F9D\u5B58\u3059\u308B\u3002\u591A\u304F\u306E\u5834\u5408\u3001\u4E88\u9632\u63A5\u7A2E\u3092\u53D7\u3051\u305F\u60A3\u8005\u306E\u611F\u67D3\u75C7\u306F\u3001\u81EA\u7136\u306B\u611F\u67D3\u3057\u305F\u5834\u5408\u3088\u308A\u3082\u75C7\u72B6\u304C\u8EFD\u304F\u3001\u671F\u9593\u3082\u77ED\u304F\u306A\u308B\u3002\u307E\u305F\u6253\u3061\u629C\u304D\u611F\u67D3\uFF08\u3046\u3061\u306C\u304D\u304B\u3093\u305B\u3093\uFF09\u3001\u7A81\u7834\u578B\u611F\u67D3\u3068\u3082\u3044\u3046\u3002"@ja ,
"\uB3CC\uD30C \uAC10\uC5FC(\u7A81\u7834\u611F\u67D3, breakthrough infection)\uC740 \uBC31\uC2E0\uC774 \uC608\uBC29\uD558\uACE0\uC790 \uD558\uB294 \uC9C8\uBCD1\uC5D0 \uC608\uBC29 \uC811\uC885\uC744 \uD55C \uC811\uC885\uC790\uAC00 \uAC78\uB9AC\uB294 \uACBD\uC6B0\uB97C \uB9D0\uD55C\uB2E4. \uAC04\uB2E8\uD788 \uB9D0\uD574 \uBC31\uC2E0\uC774 \uBAA9\uD45C\uB85C \uC124\uACC4\uB41C \uBCD1\uC6D0\uCCB4\uC5D0 \uB300\uD55C \uBA74\uC5ED\uB825\uC744 \uC81C\uACF5\uD558\uC9C0 \uBABB\uD560 \uB54C \uBC1C\uC0DD\uD55C\uB2E4. \uB3CC\uD30C \uAC10\uC5FC\uC740 \uBCFC\uAC70\uB9AC, \uC218\uB450, \uC778\uD50C\uB8E8\uC5D4\uC790 \uB4F1 \uB2E4\uC591\uD55C \uC9C8\uBCD1\uC5D0\uC11C \uC608\uBC29 \uC811\uC885\uC744 \uD55C \uAC1C\uC778\uC5D0\uAC8C\uC11C \uD655\uC778\uB418\uC5C8\uB2E4. \uB3CC\uD30C \uAC10\uC5FC\uC758 \uD2B9\uC131\uC740 \uBC14\uC774\uB7EC\uC2A4 \uC790\uCCB4\uC5D0 \uB2EC\uB824 \uC788\uB2E4. \uD754\uD788 \uC608\uBC29 \uC811\uC885\uC744 \uBC1B\uC740 \uAC1C\uC778\uC740 \uAC10\uC5FC\uB418\uB354\uB77C\uB3C4 \uAC00\uBCBC\uC6B4 \uC99D\uC0C1\uC744 \uC77C\uC73C\uD0A4\uACE0, \uC790\uC5F0\uC801\uC73C\uB85C \uAC10\uC5FC\uB41C \uACBD\uC6B0\uBCF4\uB2E4 \uCE58\uC720 \uAE30\uAC04\uC774 \uC9E7\uB2E4. \uB3CC\uD30C \uAC10\uC5FC\uC758 \uC6D0\uC778\uC73C\uB85C\uB294 \uBC31\uC2E0\uC758 \uBD80\uC801\uC808\uD55C \uD22C\uC5EC\uB098 \uBCF4\uAD00, \uBC14\uC774\uB7EC\uC2A4\uC758 \uB3CC\uC5F0\uBCC0\uC774, \uD56D\uCCB4 \uCC28\uB2E8 \uB4F1\uC774 \uC788\uB2E4. \uC774\uB7F0 \uC774\uC720\uB85C \uBC31\uC2E0\uC740 100% \uD6A8\uACFC\uAC00 \uC788\uB294 \uACBD\uC6B0\uB294 \uAC70\uC758 \uC5C6\uB2E4. \uC77C\uBC18\uC801\uC778 \uC778\uD50C\uB8E8\uC5D4\uC790 \uBC31\uC2E0\uC740 58%\uC758 \uC811\uC885\uC790\uC5D0\uAC8C \uC778\uD50C\uB8E8\uC5D4\uC790\uC5D0 \uB300\uD55C \uBA74\uC5ED\uC744 \uC81C\uACF5\uD558\uB294 \uAC83\uC73C\uB85C \uCD94\uC815\uB41C\uB2E4. \uD64D\uC5ED \uBC31\uC2E0\uC740 \uBC31\uC2E0\uC744 \uC811\uC885\uD55C \uC5B4\uB9B0\uC774 \uC911 2%\uC5D0\uAC8C \uBA74\uC5ED\uB825\uC744 \uC81C\uACF5\uD558\uC9C0 \uBABB\uD55C\uB2E4. \uADF8\uB7EC\uB098 \uC9D1\uB2E8 \uBA74\uC5ED\uC774 \uC874\uC7AC\uD55C\uB2E4\uBA74, \uBC31\uC2E0\uC758 \uD6A8\uACFC\uB97C \uBCF4\uC9C0 \uBABB\uD558\uB294 \uAC1C\uC778\uB3C4 \uC9C8\uBCD1\uC5D0 \uAC78\uB9AC\uB294 \uAC83\uC744 \uB9C9\uB294\uB2E4. \uB530\uB77C\uC11C \uC9D1\uB2E8 \uBA74\uC5ED\uC740 \uD55C \uC9D1\uB2E8\uC758 \uAC10\uC5FC\uC790 \uC218\uB97C \uD68D\uAE30\uC801\uC73C\uB85C \uAC10\uC18C\uC2DC\uD0A8\uB2E4."@ko ,
"\u7A81\u7834\u6027\u611F\u67D3\uFF08\u82F1\u8A9E\uFF1Abreakthrough infection\uFF09\u6216\u8B6F\u7A7F\u900F\u611F\u67D3\u3001\u7A81\u570D\u611F\u67D3\uFF0C\u5373\u75AB\u82D7\u5931\u6557\u7684\u611F\u67D3\uFF0C\u4E3A\u63A5\u79CD\u75AB\u82D7\u540E\u4ECD\u611F\u67D3\u6240\u5E94\u514D\u75AB\u75C5\u539F\u7684\u73B0\u8C61\uFF0C\u4EA6\u5373\u75AB\u82D7\u6CA1\u80FD\u8BA9\u63A5\u79CD\u8005\u4E0E\u5BF9\u5E94\u75C5\u6BD2\u4EA7\u751F\u514D\u75AB\uFF1B\u76EE\u524D\u4EC5\u51FA\u73B0\u5728\u5BF9\u6297\u75C5\u6BD2\u7684\u75AB\u82D7\u3002\u6D41\u884C\u6027\u816E\u817A\u708E\u3001\u6C34\u75D8\u3001\u6D41\u611F\u3001SARS-CoV-2\u7B49\u75AB\u82D7\uFF0C\u5747\u6709\u51FA\u73B0\u7A81\u7834\u6027\u611F\u67D3\u7684\u7EAA\u5F55\u3002\u81F3\u4E8E\u75AB\u82D7\u662F\u5426\u53D1\u751F\u7A81\u7834\u6027\u611F\u67D3\u8FD9\u4E2A\u7279\u70B9\uFF0C\u5219\u53D6\u51B3\u4E8E\u75C5\u6BD2\u672C\u8EAB\u7684\u7279\u6027\u3002\u901A\u5E38\uFF0C\u7A81\u7834\u6027\u611F\u67D3\u60A3\u8005\u7684\u75C7\u72B6\u8981\u6BD4\u666E\u901A\u611F\u67D3\u60A3\u8005\u7684\u8981\u8F7B\u4E00\u4E9B\uFF0C\u751A\u81F3\u662F\u7121\u75C7\u72C0\u611F\u67D3\u3002 \u7A81\u7834\u6027\u611F\u67D3\u53D1\u751F\u7684\u539F\u56E0\u5305\u62EC\uFF1A\u63A5\u79CD\u8005\u7684\u751F\u7269\u56E0\u7D20\u3001\u75AB\u82D7\u7684\u4E0D\u5F53\u6295\u4E88\u6216\u50A8\u5B58\u3001\u75C5\u6BD2\u7684\u7A81\u53D8\u3001\u7684\u5F62\u6210\uFF0C\u4EE5\u53CA\u5176\u4ED6\u56E0\u7D20\u3002\u7531\u4E8E\u8FD9\u4E9B\u539F\u56E0\uFF0C\u4E00\u79CD\u75AB\u82D7\u7684\u6548\u529B\u5F88\u5C11\u80FD\u8FBE\u5230100%\u3002\u5E38\u89C1\u7684\u6D41\u611F\u75AB\u82D7\u5927\u7EA6\u80FD\u4E3A58%\u7684\u63A5\u79CD\u8005\u63D0\u4F9B\u514D\u75AB\uFF1B\u7EA6\u67092%\u63A5\u79CD\u9EBB\u75B9\u75AB\u82D7\u7684\u513F\u7AE5\u65E0\u6CD5\u83B7\u5F97\u514D\u75AB\u6548\u679C\u3002\u7136\u800C\u5982\u679C\u7FA4\u4F53\u514D\u75AB\u5DF2\u7ECF\u4EA7\u751F\uFF0C\u4E5F\u80FD\u9632\u6B62\u514D\u75AB\u83B7\u5F97\u4E0D\u5145\u5206\u7684\u63A5\u79CD\u8005\u611F\u67D3\u75BE\u75C5\u3002\u6362\u53E5\u8BDD\u8BF4\uFF0C\u7FA4\u4F53\u514D\u75AB\u53EF\u4EE5\u964D\u4F4E\u4EBA\u7FA4\u4E2D\u7A81\u7834\u6027\u611F\u67D3\u7684\u53D1\u751F\u6982\u7387\u3002 \u65BD\u6253COVID-19\u75AB\u82D7\u4E0D\u80FD\u4FDD\u8B49\u6709\u5B8C\u5168\u4FDD\u8B77\u529B\uFF0C\u6578\u64DA\u986F\u793A\u5404\u570B\u63A5\u7A2E\u5F8C\u4ECD\u9020\u6210\u7A81\u7834\u6027\u611F\u67D3\u30022021\u5E744\u6708\uFF0C\u7F8E\u56FD\u75BE\u63A7\u4E2D\u5FC3\u62A5\u544A\u79F0\uFF0C\u7F8E\u56FD7500\u4E07COVID-19\u75AB\u82D7\u5B8C\u5168\u63A5\u79CD\u8005\u4E2D\uFF0C\u5171\u53D1\u73B05814\u4F8BCOVID-19\u7A81\u7834\u6027\u611F\u67D3\u75C5\u4F8B\uFF0C\u5305\u542B74\u4F8B\u6B7B\u4EA1\u75C5\u4F8B\u3002"@zh ,
"\u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642\u060C \u0647\u064A \u062D\u0627\u0644\u0629 \u064A\u0635\u0627\u0628 \u0641\u064A\u0647\u0627 \u0627\u0644\u0634\u062E\u0635 \u0627\u0644\u0645\u062A\u0644\u0642\u064A \u0644\u0644\u0642\u0627\u062D \u0628\u0646\u0641\u0633 \u0627\u0644\u0645\u0631\u0636 \u0627\u0644\u0630\u064A \u064A\u0647\u062F\u0641 \u0627\u0644\u0644\u0642\u0627\u062D \u0625\u0644\u0649 \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646\u0647. \u0623\u0648 \u0628\u0628\u0633\u0627\u0637\u0629 \u0623\u0643\u062B\u0631\u060C \u0647\u064A \u0627\u0644\u062D\u0627\u0644\u0629 \u0627\u0644\u062A\u064A \u062A\u0635\u0641 \u0641\u0634\u0644 \u0627\u0644\u0644\u0642\u0627\u062D\u0627\u062A \u0641\u064A \u062A\u0648\u0641\u064A\u0631 \u0645\u0646\u0627\u0639\u0629 \u0636\u062F \u0627\u0644\u0639\u0648\u0627\u0645\u0644 \u0627\u0644\u0645\u0645\u0631\u0636\u0629 \u0627\u0644\u0645\u0633\u062A\u0647\u062F\u0641\u0629. \u0633\u062C\u0644\u062A \u062D\u0627\u0644\u0627\u062A \u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642 \u0644\u062F\u0649 \u0627\u0644\u0639\u062F\u064A\u062F \u0645\u0646 \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0627\u0644\u0645\u062A\u0644\u0642\u064A\u0646 \u0644\u0644\u0642\u0627\u062D\u0627\u062A \u0645\u062A\u0646\u0648\u0639\u0629 \u0643\u0644\u0642\u0627\u062D \u0627\u0644\u0646\u0643\u0627\u0641 \u0648\u0627\u0644\u062D\u0645\u0627\u0642 (\u062C\u062F\u0631\u064A \u0627\u0644\u0645\u0627\u0621) \u0648\u0627\u0644\u0625\u0646\u0641\u0644\u0648\u0646\u0632\u0627. \u062A\u0639\u062A\u0645\u062F \u0637\u0628\u064A\u0639\u0629 \u0647\u0630\u0627 \u0627\u0644\u0646\u0648\u0639 \u0645\u0646 \u0627\u0644\u0639\u062F\u0648\u0649 \u0639\u0644\u0649 \u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u0646\u0641\u0633\u0647. \u062A\u0643\u0648\u0646 \u0623\u0639\u0631\u0627\u0636 \u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642 \u0623\u062E\u0641 \u0648\u0645\u062F\u0629 \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0623\u0642\u0635\u0631 \u0641\u064A \u0645\u0639\u0638\u0645 \u0627\u0644\u062D\u0627\u0644\u0627\u062A."@ar ;
rdfs:seeAlso dbr:Vaccine_resistance .
@prefix dcterms: .
@prefix dbc: .
dbr:Breakthrough_infection dcterms:subject dbc:Immunology ;
dbo:abstract "Una infecci\u00F3n posvacunaci\u00F3n es un caso de enfermedad en el que un individuo vacunado se enferma de la misma enfermedad que la vacuna debe prevenir. Simplemente, ocurre cuando las vacunas no logran proporcionar inmunidad contra el pat\u00F3geno para el que est\u00E1n dise\u00F1adas. Se han identificado infecciones posvacunaci\u00F3n en personas inmunizadas contra una variedad de enfermedades diferentes, incluyendo paperas, varicela e influenza.\u200B\u200B\u200B El car\u00E1cter de las infecciones posvacunaci\u00F3n depende del virus en s\u00ED. A menudo, la infecci\u00F3n en el individuo vacunado produce s\u00EDntomas m\u00E1s leves y es de menor duraci\u00F3n que si la infecci\u00F3n se contrajera naturalmente.\u200B Las causas de las infecciones posvacunaci\u00F3n incluyen la administraci\u00F3n o almacenamiento incorrectos de vacunas, mutaciones en virus y bloqueo de anticuerpos. Por estas razones, las vacunas rara vez son 100% efectivas. Se estima que la vacuna contra la gripe com\u00FAn proporciona inmunidad a la gripe en el 58% de los receptores.\u200B La vacuna contra el sarampi\u00F3n no proporciona inmunidad al 2% de los ni\u00F1os que reciben la vacuna. Sin embargo, si existe inmunidad colectiva, generalmente evita que las personas que se vacunan de manera ineficaz contraigan la enfermedad.\u200B En consecuencia, la inmunidad de grupo reduce el n\u00FAmero de infecciones de posvacunaci\u00F3n en una poblaci\u00F3n.\u200B En abril de 2021, los CDC informaron de que en Estados Unidos se produjeron 5814 infecciones por el virus COVID-19, y 74 muertes, entre los m\u00E1s de 75 millones de personas totalmente vacunadas contra el virus COVID-19.\u200B\u200B\u200B\u200B\u200B\u200B"@es ,
"Als Impfdurchbruch (auch Durchbruchsinfektion (englisch vaccine breakthrough infection) bzw. sekund\u00E4res Impfversagen) wird eine symptomatische Infektion bei einem Geimpften bezeichnet, die mittels RT-PCR-Test oder Erregerisolierung diagnostiziert wurde. F\u00FCr Impfdurchbr\u00FCche gibt es verschiedene Ursachen. Eine M\u00F6glichkeit ist eine Mutation des Pathogens, gegen das geimpft worden ist. Wenn dadurch der Erreger nicht mehr vom Immunsystem erkannt wird, kommt es trotz einer vorangegangenen Impfung oder einer \u00FCberstandenen Infektion zu einer Erkrankung."@de ,
"En genombrottsinfektion avser en infektion som sker n\u00E4r en vaccinerad individ blir sjuk av samma virus som vaccinet skulle skydda mot. Infektionen intr\u00E4ffar n\u00E4r vaccinet inte ger immunitet mot det patogen som det ska skydda mot. Genombrottsinfektioner har identifierats hos individer som har f\u00E5tt vaccin mot olika sjukdomar s\u00E5som p\u00E5ssjuka, vattkoppor och influensa. Hur sjuk en individ blir av infektionen beror p\u00E5 virustypen, men oftast f\u00E5r den som \u00E4r vaccinerad mildare symptom och under en kortare period \u00E4n om denne inte var vaccinerad. Genombrottsinfektioner kan intr\u00E4ffa av flera orsaker: felaktig administration eller f\u00F6rvaring av vaccin, mutationer hos virus och blockerande antikroppar. Detta inneb\u00E4r att vaccin s\u00E4llan \u00E4r 100 procent effektiva. Influensavaccinet uppskattas ge immunitet hos 58 procent av de vaccinerade. M\u00E4sslingsvaccinet ger skydd till 98 procent, men om flockimmunitet har uppn\u00E5tts minskar risken f\u00F6r att drabbas av en genombrottsinfektion hos icke-vaccinerade. I april 2021 rapporterade USA:s nationella folkh\u00E4lsomyndighet CDC att av 75 miljoner fullt vaccinerade personer mot covid-19 fanns det 5 814 fall av genombrottsinfektioner och 74 d\u00F6dsfall."@sv ,
"\u7A81\u7834\u6027\u611F\u67D3\uFF08\u82F1\u8A9E\uFF1Abreakthrough infection\uFF09\u6216\u8B6F\u7A7F\u900F\u611F\u67D3\u3001\u7A81\u570D\u611F\u67D3\uFF0C\u5373\u75AB\u82D7\u5931\u6557\u7684\u611F\u67D3\uFF0C\u4E3A\u63A5\u79CD\u75AB\u82D7\u540E\u4ECD\u611F\u67D3\u6240\u5E94\u514D\u75AB\u75C5\u539F\u7684\u73B0\u8C61\uFF0C\u4EA6\u5373\u75AB\u82D7\u6CA1\u80FD\u8BA9\u63A5\u79CD\u8005\u4E0E\u5BF9\u5E94\u75C5\u6BD2\u4EA7\u751F\u514D\u75AB\uFF1B\u76EE\u524D\u4EC5\u51FA\u73B0\u5728\u5BF9\u6297\u75C5\u6BD2\u7684\u75AB\u82D7\u3002\u6D41\u884C\u6027\u816E\u817A\u708E\u3001\u6C34\u75D8\u3001\u6D41\u611F\u3001SARS-CoV-2\u7B49\u75AB\u82D7\uFF0C\u5747\u6709\u51FA\u73B0\u7A81\u7834\u6027\u611F\u67D3\u7684\u7EAA\u5F55\u3002\u81F3\u4E8E\u75AB\u82D7\u662F\u5426\u53D1\u751F\u7A81\u7834\u6027\u611F\u67D3\u8FD9\u4E2A\u7279\u70B9\uFF0C\u5219\u53D6\u51B3\u4E8E\u75C5\u6BD2\u672C\u8EAB\u7684\u7279\u6027\u3002\u901A\u5E38\uFF0C\u7A81\u7834\u6027\u611F\u67D3\u60A3\u8005\u7684\u75C7\u72B6\u8981\u6BD4\u666E\u901A\u611F\u67D3\u60A3\u8005\u7684\u8981\u8F7B\u4E00\u4E9B\uFF0C\u751A\u81F3\u662F\u7121\u75C7\u72C0\u611F\u67D3\u3002 \u7A81\u7834\u6027\u611F\u67D3\u53D1\u751F\u7684\u539F\u56E0\u5305\u62EC\uFF1A\u63A5\u79CD\u8005\u7684\u751F\u7269\u56E0\u7D20\u3001\u75AB\u82D7\u7684\u4E0D\u5F53\u6295\u4E88\u6216\u50A8\u5B58\u3001\u75C5\u6BD2\u7684\u7A81\u53D8\u3001\u7684\u5F62\u6210\uFF0C\u4EE5\u53CA\u5176\u4ED6\u56E0\u7D20\u3002\u7531\u4E8E\u8FD9\u4E9B\u539F\u56E0\uFF0C\u4E00\u79CD\u75AB\u82D7\u7684\u6548\u529B\u5F88\u5C11\u80FD\u8FBE\u5230100%\u3002\u5E38\u89C1\u7684\u6D41\u611F\u75AB\u82D7\u5927\u7EA6\u80FD\u4E3A58%\u7684\u63A5\u79CD\u8005\u63D0\u4F9B\u514D\u75AB\uFF1B\u7EA6\u67092%\u63A5\u79CD\u9EBB\u75B9\u75AB\u82D7\u7684\u513F\u7AE5\u65E0\u6CD5\u83B7\u5F97\u514D\u75AB\u6548\u679C\u3002\u7136\u800C\u5982\u679C\u7FA4\u4F53\u514D\u75AB\u5DF2\u7ECF\u4EA7\u751F\uFF0C\u4E5F\u80FD\u9632\u6B62\u514D\u75AB\u83B7\u5F97\u4E0D\u5145\u5206\u7684\u63A5\u79CD\u8005\u611F\u67D3\u75BE\u75C5\u3002\u6362\u53E5\u8BDD\u8BF4\uFF0C\u7FA4\u4F53\u514D\u75AB\u53EF\u4EE5\u964D\u4F4E\u4EBA\u7FA4\u4E2D\u7A81\u7834\u6027\u611F\u67D3\u7684\u53D1\u751F\u6982\u7387\u3002 \u65BD\u6253COVID-19\u75AB\u82D7\u4E0D\u80FD\u4FDD\u8B49\u6709\u5B8C\u5168\u4FDD\u8B77\u529B\uFF0C\u6578\u64DA\u986F\u793A\u5404\u570B\u63A5\u7A2E\u5F8C\u4ECD\u9020\u6210\u7A81\u7834\u6027\u611F\u67D3\u30022021\u5E744\u6708\uFF0C\u7F8E\u56FD\u75BE\u63A7\u4E2D\u5FC3\u62A5\u544A\u79F0\uFF0C\u7F8E\u56FD7500\u4E07COVID-19\u75AB\u82D7\u5B8C\u5168\u63A5\u79CD\u8005\u4E2D\uFF0C\u5171\u53D1\u73B05814\u4F8BCOVID-19\u7A81\u7834\u6027\u611F\u67D3\u75C5\u4F8B\uFF0C\u5305\u542B74\u4F8B\u6B7B\u4EA1\u75C5\u4F8B\u3002"@zh ,
"\uB3CC\uD30C \uAC10\uC5FC(\u7A81\u7834\u611F\u67D3, breakthrough infection)\uC740 \uBC31\uC2E0\uC774 \uC608\uBC29\uD558\uACE0\uC790 \uD558\uB294 \uC9C8\uBCD1\uC5D0 \uC608\uBC29 \uC811\uC885\uC744 \uD55C \uC811\uC885\uC790\uAC00 \uAC78\uB9AC\uB294 \uACBD\uC6B0\uB97C \uB9D0\uD55C\uB2E4. \uAC04\uB2E8\uD788 \uB9D0\uD574 \uBC31\uC2E0\uC774 \uBAA9\uD45C\uB85C \uC124\uACC4\uB41C \uBCD1\uC6D0\uCCB4\uC5D0 \uB300\uD55C \uBA74\uC5ED\uB825\uC744 \uC81C\uACF5\uD558\uC9C0 \uBABB\uD560 \uB54C \uBC1C\uC0DD\uD55C\uB2E4. \uB3CC\uD30C \uAC10\uC5FC\uC740 \uBCFC\uAC70\uB9AC, \uC218\uB450, \uC778\uD50C\uB8E8\uC5D4\uC790 \uB4F1 \uB2E4\uC591\uD55C \uC9C8\uBCD1\uC5D0\uC11C \uC608\uBC29 \uC811\uC885\uC744 \uD55C \uAC1C\uC778\uC5D0\uAC8C\uC11C \uD655\uC778\uB418\uC5C8\uB2E4. \uB3CC\uD30C \uAC10\uC5FC\uC758 \uD2B9\uC131\uC740 \uBC14\uC774\uB7EC\uC2A4 \uC790\uCCB4\uC5D0 \uB2EC\uB824 \uC788\uB2E4. \uD754\uD788 \uC608\uBC29 \uC811\uC885\uC744 \uBC1B\uC740 \uAC1C\uC778\uC740 \uAC10\uC5FC\uB418\uB354\uB77C\uB3C4 \uAC00\uBCBC\uC6B4 \uC99D\uC0C1\uC744 \uC77C\uC73C\uD0A4\uACE0, \uC790\uC5F0\uC801\uC73C\uB85C \uAC10\uC5FC\uB41C \uACBD\uC6B0\uBCF4\uB2E4 \uCE58\uC720 \uAE30\uAC04\uC774 \uC9E7\uB2E4. \uB3CC\uD30C \uAC10\uC5FC\uC758 \uC6D0\uC778\uC73C\uB85C\uB294 \uBC31\uC2E0\uC758 \uBD80\uC801\uC808\uD55C \uD22C\uC5EC\uB098 \uBCF4\uAD00, \uBC14\uC774\uB7EC\uC2A4\uC758 \uB3CC\uC5F0\uBCC0\uC774, \uD56D\uCCB4 \uCC28\uB2E8 \uB4F1\uC774 \uC788\uB2E4. \uC774\uB7F0 \uC774\uC720\uB85C \uBC31\uC2E0\uC740 100% \uD6A8\uACFC\uAC00 \uC788\uB294 \uACBD\uC6B0\uB294 \uAC70\uC758 \uC5C6\uB2E4. \uC77C\uBC18\uC801\uC778 \uC778\uD50C\uB8E8\uC5D4\uC790 \uBC31\uC2E0\uC740 58%\uC758 \uC811\uC885\uC790\uC5D0\uAC8C \uC778\uD50C\uB8E8\uC5D4\uC790\uC5D0 \uB300\uD55C \uBA74\uC5ED\uC744 \uC81C\uACF5\uD558\uB294 \uAC83\uC73C\uB85C \uCD94\uC815\uB41C\uB2E4. \uD64D\uC5ED \uBC31\uC2E0\uC740 \uBC31\uC2E0\uC744 \uC811\uC885\uD55C \uC5B4\uB9B0\uC774 \uC911 2%\uC5D0\uAC8C \uBA74\uC5ED\uB825\uC744 \uC81C\uACF5\uD558\uC9C0 \uBABB\uD55C\uB2E4. \uADF8\uB7EC\uB098 \uC9D1\uB2E8 \uBA74\uC5ED\uC774 \uC874\uC7AC\uD55C\uB2E4\uBA74, \uBC31\uC2E0\uC758 \uD6A8\uACFC\uB97C \uBCF4\uC9C0 \uBABB\uD558\uB294 \uAC1C\uC778\uB3C4 \uC9C8\uBCD1\uC5D0 \uAC78\uB9AC\uB294 \uAC83\uC744 \uB9C9\uB294\uB2E4. \uB530\uB77C\uC11C \uC9D1\uB2E8 \uBA74\uC5ED\uC740 \uD55C \uC9D1\uB2E8\uC758 \uAC10\uC5FC\uC790 \uC218\uB97C \uD68D\uAE30\uC801\uC73C\uB85C \uAC10\uC18C\uC2DC\uD0A8\uB2E4. \uBBF8\uAD6D \uC9C8\uBCD1\uD1B5\uC81C\uC608\uBC29\uC13C\uD130(CDC)\uB294 2021\uB144 4\uC6D4 \uBBF8\uAD6D\uC5D0\uC11C \uCF54\uB85C\uB09819 \uBC31\uC2E0\uC744 \uC811\uC885\uC744 \uC644\uB8CC\uD55C 7\uCC9C 5\uBC31\uB9CC \uBA85 \uC774\uC0C1\uC758 \uC0AC\uB78C\uB4E4 \uC911 5,814\uBA85\uC774 \uCF54\uB85C\uB09819\uC5D0 \uB3CC\uD30C \uAC10\uC5FC\uB418\uC5B4 74\uBA85\uC774 \uC0AC\uB9DD\uD588\uB2E4\uACE0 \uBCF4\uACE0\uD588\uB2E4."@ko ,
"\u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642\u060C \u0647\u064A \u062D\u0627\u0644\u0629 \u064A\u0635\u0627\u0628 \u0641\u064A\u0647\u0627 \u0627\u0644\u0634\u062E\u0635 \u0627\u0644\u0645\u062A\u0644\u0642\u064A \u0644\u0644\u0642\u0627\u062D \u0628\u0646\u0641\u0633 \u0627\u0644\u0645\u0631\u0636 \u0627\u0644\u0630\u064A \u064A\u0647\u062F\u0641 \u0627\u0644\u0644\u0642\u0627\u062D \u0625\u0644\u0649 \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646\u0647. \u0623\u0648 \u0628\u0628\u0633\u0627\u0637\u0629 \u0623\u0643\u062B\u0631\u060C \u0647\u064A \u0627\u0644\u062D\u0627\u0644\u0629 \u0627\u0644\u062A\u064A \u062A\u0635\u0641 \u0641\u0634\u0644 \u0627\u0644\u0644\u0642\u0627\u062D\u0627\u062A \u0641\u064A \u062A\u0648\u0641\u064A\u0631 \u0645\u0646\u0627\u0639\u0629 \u0636\u062F \u0627\u0644\u0639\u0648\u0627\u0645\u0644 \u0627\u0644\u0645\u0645\u0631\u0636\u0629 \u0627\u0644\u0645\u0633\u062A\u0647\u062F\u0641\u0629. \u0633\u062C\u0644\u062A \u062D\u0627\u0644\u0627\u062A \u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642 \u0644\u062F\u0649 \u0627\u0644\u0639\u062F\u064A\u062F \u0645\u0646 \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0627\u0644\u0645\u062A\u0644\u0642\u064A\u0646 \u0644\u0644\u0642\u0627\u062D\u0627\u062A \u0645\u062A\u0646\u0648\u0639\u0629 \u0643\u0644\u0642\u0627\u062D \u0627\u0644\u0646\u0643\u0627\u0641 \u0648\u0627\u0644\u062D\u0645\u0627\u0642 (\u062C\u062F\u0631\u064A \u0627\u0644\u0645\u0627\u0621) \u0648\u0627\u0644\u0625\u0646\u0641\u0644\u0648\u0646\u0632\u0627. \u062A\u0639\u062A\u0645\u062F \u0637\u0628\u064A\u0639\u0629 \u0647\u0630\u0627 \u0627\u0644\u0646\u0648\u0639 \u0645\u0646 \u0627\u0644\u0639\u062F\u0648\u0649 \u0639\u0644\u0649 \u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u0646\u0641\u0633\u0647. \u062A\u0643\u0648\u0646 \u0623\u0639\u0631\u0627\u0636 \u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642 \u0623\u062E\u0641 \u0648\u0645\u062F\u0629 \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0623\u0642\u0635\u0631 \u0641\u064A \u0645\u0639\u0638\u0645 \u0627\u0644\u062D\u0627\u0644\u0627\u062A. \u062A\u062A\u0636\u0645\u0646 \u0627\u0644\u0623\u0633\u0628\u0627\u0628 \u0627\u0644\u0645\u062A\u0647\u0645\u0629 \u0628\u062D\u062F\u0648\u062B \u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642 \u0627\u0644\u062E\u0637\u0623 \u0641\u064A \u0637\u0631\u064A\u0642\u0629 \u0627\u0644\u0625\u0639\u0637\u0627\u0621 \u0648\u0633\u0648\u0621 \u0627\u0644\u062A\u062E\u0632\u064A\u0646 \u0648\u0627\u0644\u0637\u0641\u0631\u0627\u062A \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u064A\u0629 \u0648\u0643\u0628\u062D \u0627\u0644\u0623\u0636\u062F\u0627\u062F. \u0644\u0627 \u062A\u0643\u0648\u0646 \u0627\u0644\u0644\u0642\u0627\u062D\u0627\u062A \u0641\u0639\u0627\u0644\u0629 \u0628\u0646\u0633\u0628\u0629 100% \u0646\u062A\u064A\u062C\u0629\u064B \u0644\u0647\u0630\u0647 \u0627\u0644\u0623\u0633\u0628\u0627\u0628. \u064A\u0648\u0641\u0631 \u0644\u0642\u0627\u062D \u0627\u0644\u0625\u0646\u0641\u0644\u0648\u0646\u0632\u0627 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u0645\u0646\u0627\u0639\u0629 \u0636\u062F \u0627\u0644\u0625\u0646\u0641\u0644\u0648\u0646\u0632\u0627 \u0644\u062F\u0649 \u0646\u062D\u0648 58% \u0645\u0646 \u0627\u0644\u0645\u062A\u0644\u0642\u064A\u0646. \u064A\u0641\u0634\u0644 \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0641\u064A \u062A\u0648\u0641\u064A\u0631 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0644\u062F\u0649 \u0646\u062D\u0648 2% \u0645\u0646 \u0627\u0644\u0623\u0637\u0641\u0627\u0644 \u0627\u0644\u0645\u062A\u0644\u0642\u064A\u0646 \u0644\u0644\u0642\u0627\u062D. \u0648\u0645\u0639 \u0630\u0644\u0643\u060C \u0642\u062F \u062A\u0642\u064A \u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0642\u0637\u064A\u0639 \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0627\u0644\u0645\u062A\u0644\u0642\u064A\u0646 \u0644\u0644\u0642\u0627\u062D \u063A\u064A\u0631 \u0641\u0639\u0627\u0644 \u0645\u0646 \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u0645\u0631\u0636. \u0648\u0641\u0642\u064B\u0627 \u0644\u0630\u0644\u0643\u060C \u062A\u0642\u0644\u0644 \u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0642\u0637\u064A\u0639 \u0645\u0646 \u062D\u0627\u0644\u0627\u062A \u0639\u062F\u0648\u0649 \u0627\u0644\u0627\u062E\u062A\u0631\u0627\u0642 \u0628\u064A\u0646 \u0627\u0644\u0633\u0643\u0627\u0646. \u0641\u064A \u0623\u0628\u0631\u064A\u0644 2021\u060C \u0623\u0628\u0644\u063A \u0645\u0631\u0643\u0632 \u0627\u0644\u0633\u064A\u0637\u0631\u0629 \u0639\u0644\u0649 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0648\u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646\u0647\u0627 \u0639\u0646 \u0648\u062C\u0648\u062F 5814 \u062D\u0627\u0644\u0629 \u0639\u062F\u0648\u0649 \u0627\u062E\u062A\u0631\u0627\u0642 \u0628\u0643\u0648\u0641\u064A\u062F 19 \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u0627\u0644\u0623\u0645\u0631\u064A\u0643\u064A\u0629 \u064874 \u062D\u0627\u0644\u0629 \u0648\u0641\u0627\u0629 \u0645\u0646 \u0628\u064A\u0646 \u0623\u0643\u062B\u0631 \u0645\u0646 75 \u0645\u0644\u064A\u0648\u0646 \u0634\u062E\u0635 \u062A\u0644\u0642\u0649 \u0627\u0644\u0644\u0642\u0627\u062D \u0628\u0634\u0643\u0644 \u0643\u0627\u0645\u0644."@ar ,
"A breakthrough infection is a case of illness in which a vaccinated individual becomes infected with the illness, because the vaccine has failed to provide complete immunity against the pathogen (currently only viruses). Breakthrough infections have been identified in individuals immunized against a variety of diseases including mumps, varicella (Chickenpox), influenza, and COVID-19. The characteristics of the breakthrough infection are dependent on the virus itself. Often, infection of the vaccinated individual results in milder symptoms and shorter duration than if the infection were contracted naturally. Causes of breakthrough infections include biological factors in the recipient, improper administration or storage of vaccines, mutations in viruses, blocking antibody formation, and other factors. For these reasons, vaccines are rarely 100% effective. A 2021 study found the common flu vaccine provided immunity to the flu in 58% of recipients. The measles vaccine fails to provide immunity to 2% of children that receive the vaccine. However, if herd immunity exists, it typically prevents individuals who are ineffectively vaccinated from contracting the disease. Accordingly, herd immunity reduces the number of breakthrough infections in a population."@en ,
"Un'infezione postvaccinale \u00E8 un caso di malattia in cui un individuo vaccinato si ammala della stessa malattia che il vaccino dovrebbe prevenire. Semplicemente, si verifica quando i vaccini non riescono a fornire l'immunit\u00E0 contro l'agente patogeno a cui sono destinati. Infezioni postvaccinali sono state identificate in individui immunizzati contro una variet\u00E0 di malattie diverse, tra cui la parotite, la varicella e l'influenza. La causa delle infezioni postvaccinali dipende dal virus stesso. Spesso, l'infezione nell'individuo vaccinato provoca sintomi pi\u00F9 lievi ed \u00E8 di durata inferiore rispetto a quando l'infezione \u00E8 stata contratta normalmente. Le cause delle infezioni postvaccinali includono la somministrazione o conservazione impropria dei vaccini, le mutazioni nei virus e il blocco degli anticorpi. Per questi motivi, i vaccini sono raramente efficaci al 100%. Si stima che il comune vaccino antinfluenzale fornisca immunit\u00E0 all'influenza nel 58% dei riceventi. Il vaccino contro il morbillo non riesce a fornire l'immunit\u00E0 al 2% dei bambini che ricevono la vaccinazione. Tuttavia, l'immunit\u00E0 di gregge, se presente, in genere impedisce agli individui vaccinati in modo inefficace di contrarre la malattia. Di conseguenza, l'immunit\u00E0 di gregge riduce il numero di infezioni in una popolazione. Nell'aprile 2021, il CDC ha riferito che negli Stati Uniti ci sono state 5.814 infezioni postvaccinali da COVID-19 e 74 decessi, tra gli oltre 75 milioni di persone completamente vaccinate contro il virus SARS-CoV-2, responsabile della malattia COVID-19."@it ,
"\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\uFF08\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u304B\u3093\u305B\u3093\u3001Breakthrough infection\uFF09\u3068\u306F\u3001\u30EF\u30AF\u30C1\u30F3\u3092\u63A5\u7A2E\u3057\u305F\u60A3\u8005\u304C\u3001\u305D\u306E\u30EF\u30AF\u30C1\u30F3\u304C\u4E88\u9632\u3059\u308B\u7B48\u306E\u3082\u306E\u3068\u540C\u3058\u75C5\u539F\u4F53\u306B\u611F\u67D3\u3057\u3066\u3057\u307E\u3046\u4E8B\u3092\u6307\u3059\u3002\u30EF\u30AF\u30C1\u30F3\u3092\u6253\u3063\u3066\u3044\u3066\u3082\u611F\u67D3\u3059\u308B\u7406\u7531\u3068\u3057\u3066\u306F\u3001\u8840\u4E2D\u306B\u6297\u4F53\u304C\u5B58\u5728\u3057\u3066\u3082\u7C98\u819C\u306A\u3069\u3067\u306F\u305D\u306E\u50CD\u304D\u304C\u5F31\u304F\u4E88\u9632\u3057\u304D\u308C\u306A\u3044\u305F\u3081\u3001\u307E\u305F\u3001\u75C5\u539F\u4F53\u306E\u5909\u7570\u306B\u3088\u308A\u6297\u4F53\u304C\u5341\u5206\u306B\u50CD\u304B\u305A\u306B\u611F\u67D3\u3057\u3066\u3057\u307E\u3046\u3053\u3068\u304C\u8003\u3048\u3089\u308C\u308B\u3002\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\u306F\u3001\u304A\u305F\u3075\u304F\u98A8\u90AA\u3001\u6C34\u75B1\u7621\u3001\u30A4\u30F3\u30D5\u30EB\u30A8\u30F3\u30B6\u306A\u3069\u3001\u69D8\u3005\u306A\u75C5\u6C17\u306E\u4E88\u9632\u63A5\u7A2E\u3092\u53D7\u3051\u305F\u60A3\u8005\u306B\u78BA\u8A8D\u3055\u308C\u3066\u3044\u308B\u3002\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\u306E\u7279\u5FB4\u306F\u3001\u30A6\u30A4\u30EB\u30B9\u81EA\u4F53\u306B\u4F9D\u5B58\u3059\u308B\u3002\u591A\u304F\u306E\u5834\u5408\u3001\u4E88\u9632\u63A5\u7A2E\u3092\u53D7\u3051\u305F\u60A3\u8005\u306E\u611F\u67D3\u75C7\u306F\u3001\u81EA\u7136\u306B\u611F\u67D3\u3057\u305F\u5834\u5408\u3088\u308A\u3082\u75C7\u72B6\u304C\u8EFD\u304F\u3001\u671F\u9593\u3082\u77ED\u304F\u306A\u308B\u3002\u307E\u305F\u6253\u3061\u629C\u304D\u611F\u67D3\uFF08\u3046\u3061\u306C\u304D\u304B\u3093\u305B\u3093\uFF09\u3001\u7A81\u7834\u578B\u611F\u67D3\u3068\u3082\u3044\u3046\u3002 \u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\u306E\u539F\u56E0\u306B\u306F\u3001\u30EF\u30AF\u30C1\u30F3\u306E\u4E0D\u9069\u5207\u306A\u6295\u4E0E\u3084\u4FDD\u7BA1\u3001\u30A6\u30A4\u30EB\u30B9\u306E\u7A81\u7136\u5909\u7570\u3001\u6297\u4F53\u306B\u3088\u308B\u906E\u65AD\u306A\u3069\u304C\u3042\u308B\u3002\u3053\u308C\u3089\u306E\u7406\u7531\u304B\u3089\u3001\u30EF\u30AF\u30C1\u30F3\u306E\u52B9\u679C\u304C100\uFF05\u3067\u3042\u308B\u3053\u3068\u306F\u6B86\u3069\u306A\u3044\u3002\u4E00\u822C\u7684\u306A\u30A4\u30F3\u30D5\u30EB\u30A8\u30F3\u30B6\u30EF\u30AF\u30C1\u30F3\u3067\u306F\u3001\u63A5\u7A2E\u8005\u306E58\uFF05\u304C\u30A4\u30F3\u30D5\u30EB\u30A8\u30F3\u30B6\u306B\u5BFE\u3059\u308B\u514D\u75AB\u3092\u7372\u5F97\u3067\u304D\u308B\u3068\u63A8\u5B9A\u3055\u308C\u3066\u3044\u308B\u3002\u9EBB\u75B9\u30EF\u30AF\u30C1\u30F3\u306F\u3001\u63A5\u7A2E\u3057\u305F\u5B50\u4F9B\u306E2\uFF05\u306B\u514D\u75AB\u304C\u51FA\u6765\u306A\u3044\u3068\u3055\u308C\u3066\u3044\u308B\u3002\u3057\u304B\u3057\u3001\u96C6\u56E3\u514D\u75AB\u304C\u5B58\u5728\u3059\u308B\u5834\u5408\u3001\u901A\u5E38\u3001\u52B9\u679C\u306E\u306A\u3044\u30EF\u30AF\u30C1\u30F3\u63A5\u7A2E\u3092\u53D7\u3051\u305F\u60A3\u8005\u304C\u75C5\u6C17\u306B\u611F\u67D3\u3059\u308B\u306E\u3092\u9632\u3050\u4E8B\u304C\u51FA\u6765\u308B\u3002\u5F93\u3063\u3066\u3001\u96C6\u56E3\u514D\u75AB\u306F\u3001\u96C6\u56E3\u306B\u304A\u3051\u308B\u30D6\u30EC\u30A4\u30AF\u30B9\u30EB\u30FC\u611F\u67D3\u306E\u6570\u3092\u6E1B\u5C11\u3055\u305B\u308B\u3002"@ja ;
dbo:wikiPageWikiLink dbr:Aseptic_meningitis ,
dbr:Immunological_memory ,
dbr:COVID-19_pandemic_deaths ,
dbr:Memory_T_cell ,
dbr:Immunosuppression ,
dbr:COVID-19 ,
dbr:Epitope ,
dbr:Mutation ,
dbr:Humoral_immunity ,
dbr:Pathogen ,
dbr:B-cell_receptor ,
dbr:SARS-CoV-2_Delta_variant ,
dbr:Influenza ,
dbr:Lymphoid_progenitor_cell ,
dbr:Naive_B_cell ,
dbr:Maternal_antibodies ,
dbr:Myeloid_progenitor_cells ,
dbr:Variants_of_SARS-CoV-2 ,
dbr:Maculopapular_rash ,
dbr:Hepatitis_B_vaccine ,
dbr:Antigenic_drift ,
dbr:TDaP ,
dbr:Blocking_antibody ,
dbr:Inactivated_vaccine ,
dbr:Subunit_vaccine ,
,
dbr:Telomere ,
dbr:Mumps ,
dbr:COVID-19_virus ,
dbr:Hepatitis_B_virus ,
dbr:MMR_vaccine ,
dbr:Encephalitis ,
dbr:Fc_receptor ,
dbc:Immunology ,
dbr:Varicella_vaccine ,
dbr:Virus ,
dbr:Adaptive_immune_system ,
dbr:Herd_immunity ,
dbr:Pneumococcal_vaccine ,
dbr:Measles_vaccine ,
dbr:Papule ,
dbr:Attenuated_vaccine ,
dbr:Hematopoietic_stem_cell ,
dbr:Memory_B_cell ,
dbr:Chickenpox ,
dbr:COVID-19_vaccine ,
dbr:Cohort_study ,
dbr:Naive_T_cell ,
dbr:Immunosenescence ,
dbr:Centers_for_Disease_Control_and_Prevention ,
dbr:Vaccine ,
dbr:Hepatitis_B .
@prefix dbp: .
@prefix dbt: .
dbr:Breakthrough_infection dbp:wikiPageUsesTemplate dbt:Short_description ,
dbt:Reflist ,
dbt:Concepts_in_infectious_disease ,
dbt:Portal_bar ,
dbt:See_also ,
dbt:Webarchive ;
dbo:wikiPageRevisionID 1107757077 ;
dbo:wikiPageExternalLink ,
,
,
.
@prefix xsd: .
dbr:Breakthrough_infection dbo:wikiPageLength "22578"^^xsd:nonNegativeInteger ;
dbo:wikiPageID 8077915 .
@prefix dbpedia-sv: .
dbr:Breakthrough_infection owl:sameAs dbpedia-sv:Genombrottsinfektion ,
,
.
@prefix dbpedia-it: .
dbr:Breakthrough_infection owl:sameAs dbpedia-it:Infezione_postvaccinale ,
.
@prefix wikidata: .
dbr:Breakthrough_infection owl:sameAs wikidata:Q4959681 ,
,
.
@prefix dbpedia-simple: .
dbr:Breakthrough_infection owl:sameAs dbpedia-simple:Breakthrough_infection ,
dbr:Breakthrough_infection ,
.
@prefix dbpedia-de: .
dbr:Breakthrough_infection owl:sameAs dbpedia-de:Impfdurchbruch ,
,
,
,
.
@prefix gold: .
dbr:Breakthrough_infection gold:hypernym dbr:Infection .
@prefix prov: .
dbr:Breakthrough_infection prov:wasDerivedFrom ;
foaf:isPrimaryTopicOf wikipedia-en:Breakthrough_infection ;
dbp:url ;
dbp:date "2011-01-13"^^xsd:date .
dbr:Vaccine_passports_during_the_COVID-19_pandemic dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Brianna_Keilar dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Index_of_immunology_articles dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:COVID-19_pandemic dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:COVID-19_pandemic_in_British_Columbia dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Vaccine_resistance rdfs:seeAlso dbr:Breakthrough_infection .
dbr:Varicella_zoster_virus dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Catt_Sadler dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:The_Wendy_Williams_Show dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Wendy_Williams dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Jason_Crow dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Face_masks_during_the_COVID-19_pandemic_in_the_United_States dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:COVID-19_vaccine dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Vaccine dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:COVID-19_pandemic_in_Rhode_Island dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Timeline_of_the_COVID-19_pandemic_in_Nevada dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:Workplace_hazard_controls_for_COVID-19 dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:SARS-CoV-2_Omicron_variant dbo:wikiPageWikiLink dbr:Breakthrough_infection .
dbr:COVID-19_breakthrough_infection dbo:wikiPageWikiLink dbr:Breakthrough_infection ;
dbo:wikiPageRedirects dbr:Breakthrough_infection .
dbr:Breakthrough_COVID-19_infection dbo:wikiPageWikiLink dbr:Breakthrough_infection ;
dbo:wikiPageRedirects dbr:Breakthrough_infection .
dbr:Breakthrough_case dbo:wikiPageWikiLink dbr:Breakthrough_infection ;
dbo:wikiPageRedirects dbr:Breakthrough_infection .
dbr:Vaccine_breakthrough dbo:wikiPageWikiLink dbr:Breakthrough_infection ;
dbo:wikiPageRedirects dbr:Breakthrough_infection .
dbr:Breakthrough dbo:wikiPageWikiLink dbr:Breakthrough_infection ;
dbo:wikiPageDisambiguates dbr:Breakthrough_infection .